Skip to content

The Short Physical Performance Battery in Chronic Obstructive Pulmonary Disease (COPD)

The Short Physical Performance Battery in COPD - Possible Impact of a Pulmonary Rehabilitation Program and Relationships to Other Physical Performance Measures, Symptoms, and Quality of Life.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02314338
Enrollment
50
Registered
2014-12-11
Start date
2014-09-30
Completion date
2015-12-31
Last updated
2016-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

Patients with COPD often have limitations to physical performance. There are several tests for evaluating physical performance, unfortunately many of them can be time consuming and require specialized equipment an substantial space. Short physical performance battery is a simple test that requires little resources and can be performed both at institutions and in the homes of patients. SPPB has high predictive abilities in identifying older adults at greater risk for mortality, nursing home admission, hospitalization, and incidence of disability. The investigators would like to evaluate possible changes in the SPPB score after a 4-week rehabilitation program. The investigators would also like to look at possible relationships between the SPPB and other physical performance measures, dyspnea, anxiety, depression, fatigue, and health related quality of life.

Interventions

OTHERPulmonary rehabilitation

In-patient pulmonary rehabilitation including individualized exercise prescription, group based exercise training, education, individual sessions with a multi professional health care team

Sponsors

Lovisenberg Diakonale Hospital
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER
LHL Helse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with all stages of COPD * Decision making capacity to provide informed written consent * Ability to understand and complete the questionnaires

Exclusion criteria

* Exacerbation within the last four weeks * Co-morbidities that limits the patient's physical performance more than COPD * Any patient whom is deemed unsafe to exercise * Patients tested on treadmill protocol 4 (i.e. Glittre testing protocol)

Design outcomes

Primary

MeasureTime frameDescription
Short physical performance battery (SPPB)Pre and posttest with 4 weeks in betweenSPPB is comprised of 3 tasks: a hierarchial standing balance test (side by side, semi-tandem and tandem), 4-m habitual gait speed, and 5 sit to stand from a chair. Each task is scored (based on time) from 0-4 Points (p) and then summarized into a total score of 0-12 p, where 12 p represents the highest performance.

Secondary

MeasureTime frameDescription
6-minute walk test (6MWT)4 weeksThe 6 MWT is a timed walk test. Participants are asked to walk as far as possible, in 6 minutes. Borg CR-10 score and SpO2 will be measured before, during and/or after the 6 MWT.
Borg category ratio-10 scale (Borg CR-10 scale)4 weeksThe Borg CR-10 scale is a rating scale for self-reported symptoms, in this case dyspnea. 0 represents no symptoms and 10 the worst previously experienced symptoms.
Peripheral oxygenation level4 weeksPeripheral oxygenation level (SpO2) will be measured indirectly by pulse oximetry during the 6 MWT.
Bilateral leg press 1 repetition Maximum (RM)4 weeks1 RM bilateral leg press will be administered, after a brief warm-up, as a measure of leg strength. Starting position: Legs shoulder width apart and knee at 90 degrees angle.
Lung function4 weeksspirometry and/or whole body plethysmography
COPD assessment test (CAT)4 weeksCAT is a disease-specific quality of life questionnaire. It has 8-items and a total range of 0-40, where 40 represents more severe impact of COPD on a patient's life.
Hospital anxiety and depression scale (HADS)4 weeks14-item questionnaire for screening for anxiety and depression. Each item is scored from 0-3 and each person can have a score between 0-21 for either anxiety or depression.
Fatigue severity scale (FSS)4 weeks9- item scale that measures the impact of fatigue on a person's activities and lifestyle. Range 9-63. Higher score- greater fatigue severity.
Modified Medical Research Council Dyspnea Scale (MMRC)4 weeksA score from 0-4 is used to classify the impact of dyspnea on physical function in patients with COPD. 0 represents a person who suffers from dyspnea only with strenuous exercise. 4 is a person who are to breathless to leave the house, or breathless when dressing/undressing.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026